Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 4 INDUSTRY 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 2 poly ICLC 1 Radiosurgery 1 Nivolumab 1 Immunoglobulins, Intravenous 1 Diet 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Carcinoma, Non-Small-Cell Lung × poly ICLC × Clear all

NCT06064279 2024-09-19

HAITEN-ICI

VA Office of Research and Development

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡